The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.

IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown that ...

Trump administration’s project to recover the USA’s ‘unipolar moment’ in the face of relative decline occasioned by the rise ...

Infusion therapy sends medication directly into the bloodstream to treat multiple sclerosis. Infusions can take four or more hours, and comfort items like blankets may be offered. Common ...